Review: taking Hydroxyzine pamoate and Flexeril together


Summary

Drug interactions are reported among people who take Hydroxyzine pamoate and Flexeril together. This review analyzes the effectiveness and drug interactions between Hydroxyzine pamoate and Flexeril. It is created by eHealthMe based on reports of 55 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Hydroxyzine pamoate and Flexeril >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Hydroxyzine Pamoate

Hydroxyzine pamoate has active ingredients of hydroxyzine pamoate. It is often used in stress and anxiety. (latest outcomes from Hydroxyzine pamoate 988 users)

Flexeril

Flexeril has active ingredients of cyclobenzaprine. It is often used in muscle spasms. (latest outcomes from Flexeril 16,144 users)

On Jul, 20, 2016

55 people who take Hydroxyzine Pamoate, Flexeril are studied.


Number of reports submitted per year:

Hydroxyzine pamoate and Flexeril drug interactions.

Drug effectiveness over time:

Hydroxyzine Pamoate:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Flexeril:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Hydroxyzine Pamoate:
  • female: 40.0% - (2 of 5 people)
  • male: 50.0% - (1 of 2 people)
Flexeril:
  • female: 60.0% - (3 of 5 people)
  • male: 0.0% - (0 of 2 people)

Drug effectiveness by age:

Hydroxyzine Pamoate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 33.0% - (1 of 3 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 0 people)
Flexeril:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 33.0% - (1 of 3 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 50.0% - (1 of 2 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • completed suicide
  • initial insomnia
1 - 6 months:
  • abdominal pain upper
  • anxiety disorder due to a general medical condition
  • constipation aggravated
  • difficulty breathing
  • non-cardiac chest pain
  • pain exacerbated
  • petechiae
  • initial insomnia
1 - 2 years:
  • bronchitis chronic
  • chronic asthma
  • copd
  • depression
  • dizziness (excl vertigo)
  • eye inflammation
  • eyes - sensitive to light
  • headache - mixed tension migraine
  • leukocytosis
  • rhinitis allergic
5 - 10 years:
  • shoplifting
10+ years:
  • bronchitis chronic
  • chronic asthma
  • copd
  • depression
  • dizziness (excl vertigo)
  • eye inflammation
  • eyes - sensitive to light
  • headache - mixed tension migraine
  • leukocytosis
  • rhinitis allergic
not specified:
  • pain
  • abdominal pain
  • arthralgia
  • loss of consciousness
  • vomiting
  • chest pain
  • diabetes mellitus
  • fall
  • diarrhoea
  • bone disorder

Most common drug interactions by gender *:

female:
  • abdominal pain
  • pain
  • arthralgia
  • loss of consciousness
  • vomiting
  • chest pain
  • fall
  • diarrhoea
  • bone disorder
  • diabetes mellitus
male:
  • enteritis
  • intestinal obstruction
  • memory impairment
  • nasopharyngitis
  • nausea
  • pain
  • pneumonia
  • secondary immunodeficiency
  • depression
  • glycosylated haemoglobin increased

Most common drug interactions by age *:

10-19:
  • cardiac arrest
  • completed suicide
  • respiratory arrest
20-29:
  • diplopia
  • strabismus
  • accommodation disorder
  • visual acuity reduced
  • cholelithiasis
  • death
  • nephrolithiasis
  • overdose
  • pupillary reflex impaired
30-39:
  • abdominal pain upper
  • anxiety disorder due to a general medical condition
  • completed suicide
  • constipation aggravated
  • diabetes mellitus
  • difficulty breathing
  • initial insomnia
  • non-cardiac chest pain
  • pain exacerbated
  • petechiae
40-49:
  • pneumonia
  • completed suicide
  • memory impairment
  • nasopharyngitis
  • chest pain
  • diabetes mellitus
  • abdominal pain
  • abdominal pain upper
  • burning sensation
  • cerebrovascular accident
50-59:
  • pain
  • arthralgia
  • fall
  • bone disorder
  • femur fracture
  • fracture displacement
  • fracture nonunion
  • groin pain
  • low turnover osteopathy
  • mobility decreased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Hydroxyzine pamoate and Flexeril?

Can you answer these questions?

More questions for: Hydroxyzine pamoate, Flexeril

You may be interested in these reviews

More reviews for: Hydroxyzine pamoate, Flexeril

On eHealthMe, Hydroxyzine pamoate (hydroxyzine pamoate) is often used to treat stress and anxiety. Flexeril (cyclobenzaprine) is often used to treat muscle spasms. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.